Business Context and Reporting Period
Company: Blaize Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 22, 2026
Event: Entry into a Material Definitive Agreement and Material Modification to Rights of Security Holders via the adoption of a Poison Pill (Rights Plan).
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure modifications.
Material Changes Versus Prior Period
- Adoption of Rights Plan: The Company entered into a Rights Agreement with Continental Stock Transfer & Trust Company.
- Dividend Declaration: A dividend of one preferred stock purchase right (Right) per share of Common Stock was declared for holders of record as of May 6, 2026.
- Capital Structure Modification: Creation of Series A Junior Participating Preferred Stock, with 6,000,000 shares initially reserved for issuance upon exercise of Rights.
- Anti-Takeover Mechanism: Implementation of a plan designed to deter unsolicited takeover attempts by causing substantial dilution to any person or group acquiring 10% or more of the Common Stock without Board approval.
Guidance, Outlook, and Management Commentary
Purpose of the Plan: Management states the Rights are designed to assure fair and equal treatment for all stockholders in the event of a proposed takeover and to guard against partial tender offers, open market accumulations, and coercive tactics.
Key Terms of the Rights Plan:
- Trigger Threshold: The plan activates if a person or group acquires 10% or more of the Common Stock (an "Acquiring Person").
- Exercise Price: $11.00 per one one-hundredth of a share of Series A Preferred.
- Expiration: April 21, 2027, unless earlier redeemed, exchanged, or terminated.
- Redemption: The Board may redeem the Rights in whole at $0.01 per Right at any time prior to the acquisition of 10% by an Acquiring Person.
- Flip-In/Flip-Over Provisions: Upon triggering, holders (excluding the Acquiring Person) may purchase shares with a market value of two times the Purchase Price, or exchange Rights for Common Stock at a 1:1 ratio.
- Existing Holders: Persons owning 10% or more prior to the announcement are exempt from the "Acquiring Person" definition unless they acquire additional shares.
Risks and Contingencies: The filing notes that the Rights will cause substantial dilution to an Acquiring Person. The plan includes anti-dilution provisions and allows for adjustments to the Purchase Price.
Important Facts for Investor Verification
- Verify the Record Date of May 6, 2026, to determine eligibility for the Rights dividend.
- Confirm the current beneficial ownership percentages of major shareholders to assess if any are currently exempt as "Existing Holders."
- Review the full text of the Rights Agreement (Exhibit 4.1) and Certificate of Designations (Exhibit 3.1) for specific adjustment formulas and voting rights of the Series A Preferred.
- Monitor for any Board announcements regarding the redemption of Rights at the $0.01 price point.
- Check for any subsequent filings regarding the exercise of Rights or changes to the 10% ownership threshold.